We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRST icon
4301
Primis Financial Corp
FRST
$413M
$10K ﹤0.01%
720
+91
+14% +$1.34K
FSM icon
4302
Fortuna Silver Mines
FSM
$3.16B
$10K ﹤0.01%
2,754
-13,752
-83% -$52K
GLRE icon
4303
Greenlight Captial
GLRE
$514M
$10K ﹤0.01%
1,358
+16
+1% +$116
GLSI icon
4304
Greenwich LifeSciences
GLSI
$247M
$10K ﹤0.01%
495
-401
-45% -$8.11K
GSM icon
4305
FerroAtlántica
GSM
$820M
$10K ﹤0.01%
1,336
+619
+86% +$4.22K
HGTY icon
4306
Hagerty
HGTY
$1.32B
$10K ﹤0.01%
881
-1,247
-59% -$17.8K
ICU icon
4307
SeaStar Medical
ICU
$12.7M
$10K ﹤0.01%
+4
New +$10.1K
IGIB icon
4308
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$10K ﹤0.01%
+183
New +$10.4K
IIIV icon
4309
i3 Verticals
IIIV
$294M
$10K ﹤0.01%
343
-211
-38% -$5.2K
IMRN
4310
Immuron
IMRN
$8.88M
$10K ﹤0.01%
+3,037
New +$9.79K
IMRX icon
4311
Immuneering
IMRX
$327M
$10K ﹤0.01%
1,516
+206
+16% +$1.98K
ING icon
4312
ING
ING
$102B
$10K ﹤0.01%
1,000
-1,415
-59% -$18.4K
INGN icon
4313
Inogen
INGN
$153M
$10K ﹤0.01%
313
-1,949
-86% -$61.3K
INZY
4314
DELISTED
Inozyme Pharma
INZY
$10K ﹤0.01%
2,430
+1,028
+73% +$6.05K
IPSC icon
4315
Century Therapeutics
IPSC
$348M
$10K ﹤0.01%
794
-2,271
-74% -$30.1K
JBSS icon
4316
John B. Sanfilippo & Son
JBSS
$1.01B
$10K ﹤0.01%
118
-226
-66% -$18.7K
LEXX icon
4317
Lexaria Bioscience
LEXX
$14.9M
$10K ﹤0.01%
204
+124
+155% +$7.02K
LVO icon
4318
LiveOne
LVO
$57.2M
$10K ﹤0.01%
1,249
+157
+14% +$1.37K
MATW icon
4319
Matthews International
MATW
$725M
$10K ﹤0.01%
317
-162
-34% -$5.55K
DFTX
4320
Definium Therapeutics
DFTX
$5.73B
$10K ﹤0.01%
608
-66
-10% -$1.15K
MOBX icon
4321
Mobix Labs
MOBX
$19.3M
$10K ﹤0.01%
100
-3
-3% -$296
NOBL icon
4322
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$10K ﹤0.01%
216
-358
-62% -$16.8K
NTST
4323
NETSTREIT Corp
NTST
$2.1B
$10K ﹤0.01%
426
-22
-5% -$487
NUWE icon
4324
Nuwellis
NUWE
$477K
0
NUVL
4325
DELISTED
Nuvalent
NUVL
$10K ﹤0.01%
736
-1,192
-62% -$17.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.